These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31005214)

  • 1. Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort.
    Nomden CN; Pötter R; de Leeuw AAC; Tanderup K; Lindegaard JC; Schmid MP; Fortin I; Haie-Meder C; Mahantshetty U; Hoskin P; Segedin B; Bruheim K; Rai B; Huang F; Cooper R; Van Der Steen Banasik E; Van Limbergen E; Jürgenliemk-Schulz IM;
    Radiother Oncol; 2019 May; 134():185-190. PubMed ID: 31005214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis.
    Peters M; de Leeuw AAC; Nomden CN; Tanderup K; Kirchheiner K; Lindegaard JC; Kirisits C; Haie-Meder C; Sturdza A; Fokdal L; Mahantshetty U; Hoskin P; Segedin B; Bruheim K; Rai B; Huang F; Cooper R; van der Steen-Banasik E; van Limbergen E; Pieters BR; Tan LT; van Rossum PSN; Nesvacil N; Nout R; Schmid MP; Pötter R; Jürgenliemk-Schulz IM;
    Radiother Oncol; 2021 Oct; 163():150-158. PubMed ID: 34480958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer.
    Lindegaard JC; Assenholt M; Ramlov A; Fokdal LU; Alber M; Tanderup K
    Acta Oncol; 2017 Nov; 56(11):1479-1486. PubMed ID: 28849684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer.
    Bacorro W; Dumas I; Escande A; Gouy S; Bentivegna E; Morice P; Haie-Meder C; Chargari C
    Gynecol Oncol; 2018 Mar; 148(3):461-467. PubMed ID: 29325690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
    Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer.
    Ramlov A; Kroon PS; Jürgenliemk-Schulz IM; De Leeuw AA; Gormsen LC; Fokdal LU; Tanderup K; Lindegaard JC
    Acta Oncol; 2015; 54(9):1567-73. PubMed ID: 26271799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study.
    Najjari Jamal D; Pötter R; Haie-Meder C; Lindegaard JC; Juergenliemk-Schulz IM; Mahantshetty U; Segedin B; Bruheim K; Hoskin P; Rai B; Wiebe E; Cooper R; Tanderup K; Kirchheiner K;
    Radiother Oncol; 2018 Jun; 127(3):449-455. PubMed ID: 29631933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Mohamed SM; Aagaard T; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
    Brachytherapy; 2015; 14(1):56-61. PubMed ID: 25176182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of image-guided adaptive brachytherapy to pelvic nodes treatment in locally advanced cervical cancer.
    Bacorro W; Dumas I; Levy A; Rivin Del Campo E; Canova CH; Felefly T; Huertas A; Marsolat F; Haie-Meder C; Chargari C; Mazeron R
    Brachytherapy; 2017; 16(2):366-372. PubMed ID: 28159552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does external beam radiation boost to pelvic lymph nodes improve outcomes in patients with locally advanced cervical cancer?
    Wujanto C; Choo BA; Tan D; Ilancheran A; Ng J; Low JJH; Shen L; Tang J; Koh V
    BMC Cancer; 2019 Apr; 19(1):385. PubMed ID: 31023261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of nodal boost irradiation and MR-based brachytherapy on oncologic outcomes in node-positive cervical cancer.
    Tiwari R; Narayanan GS; Reddy VP; Vishwanathan B; Narayanan S; Venugopal R
    Gynecol Oncol; 2021 Oct; 163(1):110-116. PubMed ID: 34304907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reviewing the role of parametrial boost in patients with cervical cancer with clinically involved parametria and staged with positron emission tomography.
    Rajasooriyar C; Van Dyk S; Lindawati M; Bernshaw D; Kondalsamy-Chennakesavan S; Narayan K
    Int J Gynecol Cancer; 2012 Nov; 22(9):1532-7. PubMed ID: 23027037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External beam boost irradiation for clinically positive pelvic nodes in patients with uterine cervical cancer.
    Ariga T; Toita T; Kasuya G; Nagai Y; Inamine M; Kudaka W; Kakinohana Y; Aoki Y; Murayama S
    J Radiat Res; 2013 Jul; 54(4):690-6. PubMed ID: 23365264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who can benefit from a lymph node boost in definitive chemoradiotherapy for node-positive cervical cancer: an evaluation of nodal failure in patients without nodal boost.
    Kim H; Park W; Cho WK
    J Radiat Res; 2020 May; 61(3):479-486. PubMed ID: 32211854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases.
    Chung YL; Horng CF; Lee PI; Chen FL
    BMC Cancer; 2016 Mar; 16():179. PubMed ID: 26940959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
    Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation.
    Lin AJ; Ma S; Markovina S; Schwarz J; Mutch DG; Powell MA; Grigsby PW
    Gynecol Oncol; 2019 Jun; 153(3):530-534. PubMed ID: 30905434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG-PET/CT guided external beam radiotherapy volumes in inoperable uterine cervical cancer.
    Adam JA; Arkies H; Hinnen K; Stalpers LJ; van Waesberghe JH; Stoker J; van Os R; Laan JJ; Mom CH; van Eck-Smit BL
    Q J Nucl Med Mol Imaging; 2018 Dec; 62(4):420-428. PubMed ID: 29869485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
    Snyder JE; Willett AB; Sun W; Kim Y
    Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.